Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.38
Delayed Data
As of 3:59pm ET
 0.0001 / +0.03%
Today’s Change
0.17
Today|||52-Week Range
0.50
0.00%
Year-to-Date
Good Companies From Warren Buffett's Portfolio
Jun 23 / GuruFocus News - Paid Partner Content
4 Buy-Ranked Large Cap Pharma Stocks to Add to Your Portfolio
Jun 20 / Zacks.com - Paid Partner Content
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Jun 23 / Zacks.com - Paid Partner Content
Sanofi: Should Value Investors Consider SNY Stock?
Jun 19 / Zacks.com - Paid Partner Content
Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout
Jun 23 / TheStreet.com - Paid Partner Content
Pfizer (PFE) Buys Exclusive EU Rights to Anti-Fungal Drug
Jun 15 / Zacks.com - Paid Partner Content
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
Jun 22 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) Presents Data for Type II Diabetes Drug
Jun 14 / Zacks.com - Paid Partner Content
Why You Should Add Novo Nordisk Stock to Your Portfolio
Jun 22 / Zacks.com - Paid Partner Content
Intercept (ICPT) Releases Data from Phase II Flint Trial
Jun 13 / Zacks.com - Paid Partner Content
Seattle Genetics (SGEN) Submits BLA to FDA for Cancer Drug
Jun 21 / Zacks.com - Paid Partner Content
Seres Therapeutics' Stock Up as SER-109 Moves to Phase III
Jun 13 / Zacks.com - Paid Partner Content
Horizon Pharma Gets Health Canada Approval for Procysbi
Jun 20 / Zacks.com - Paid Partner Content